What Is Ozempic? A Plain-Language Explainer

Ozempic has become one of the most talked-about medications in recent memory, but the name itself explains almost nothing about what it does. Here’s a plain-language look at what’s actually in the pen, how it works in the body, and why it’s easy to confuse with Wegovy and Rybelsus.

Dumbbell, weight, fitness — illustrating What Is Ozempic? A Plain-Language Explainer

What Ozempic actually is

Ozempic is the brand name for semaglutide, an injectable medication made by Novo Nordisk. It belongs to a class of drugs called GLP-1 receptor agonists — GLP-1 stands for glucagon-like peptide-1, a hormone the gut releases naturally after eating. The FDA approved Ozempic in December 2017 to improve blood sugar control in adults with type 2 diabetes, alongside diet and exercise. In 2020, the agency added a second approval: reducing the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) in adults with type 2 diabetes who already have established heart disease.

Ozempic comes as a prefilled injection pen used once a week, typically in the abdomen, thigh, or upper arm. Treatment starts low and increases gradually — usually 0.25 mg weekly for the first month, a dose meant to let the body adjust rather than to control blood sugar, then stepping up to 0.5 mg, and if needed to 1 mg or the maximum 2 mg weekly dose, depending on how a person responds and tolerates it. This titration schedule is the main reason side effects tend to be worse early in treatment or right after a dose increase.

How it works in the body

GLP-1 is released from the small intestine after meals and does several things at once. Semaglutide is engineered to resemble this hormone closely enough to bind the same receptors, but it’s modified so it lasts for days instead of minutes, which is what allows once-weekly dosing.

The practical effects fall into three buckets:

Glucose-dependent insulin release. The pancreas secretes more insulin when blood sugar is elevated, and less when it’s not — a built-in safeguard that makes severe low blood sugar less likely with semaglutide alone than with older diabetes drugs like sulfonylureas.
Slower gastric emptying. Food leaves the stomach more slowly, which blunts the after-meal blood sugar spike and contributes to the feeling of fullness many people report.
Reduced appetite. GLP-1 receptors are also present in appetite-regulating regions of the brain, which is why semaglutide reliably produces weight loss as a side effect even when it’s prescribed strictly for diabetes.

That last point is the crux of why semaglutide became a cultural phenomenon: a drug developed to manage blood sugar turned out to be one of the most effective weight-loss agents ever approved, which led Novo Nordisk to develop a dedicated obesity formulation.

Ozempic was approved and studied as a diabetes drug — the weight loss people talk about is a real, well-documented effect of the same mechanism, not an unrelated bonus.

Weight plates, power, weight training — illustrating What Is Ozempic? A Plain-Language Explainer

Ozempic vs. Wegovy vs. Rybelsus

All three are semaglutide from the same manufacturer, but they are not the same product, and using the names loosely causes real confusion.

	Ozempic	Wegovy	Rybelsus
Form	Weekly injection	Weekly injection	Daily oral tablet
FDA-approved use	Type 2 diabetes; CV risk reduction	Chronic weight management	Type 2 diabetes
Max approved dose	2 mg/week	2.4 mg/week	14 mg/day
First approved	2017	2021	2019

Wegovy uses the same molecule at a higher maximum dose and was studied specifically in people with obesity or overweight plus a weight-related condition, largely in the STEP trial program. Rybelsus delivers semaglutide as a pill rather than an injection — a harder engineering problem, since peptides are normally broken down in the stomach, which is why the tablet is combined with an absorption enhancer and must be taken on an empty stomach with a small amount of water.

Prescribing Ozempic specifically for weight loss is considered off-label use. It happens in practice, but it means the prescription wasn’t tested or approved by the FDA for that purpose at that dose, and insurance is far less likely to cover it under that intent.

Sports, fitness, training — illustrating What Is Ozempic? A Plain-Language Explainer

What using it actually feels like

Gastrointestinal side effects are by far the most common complaint: nausea, constipation, diarrhea, vomiting, and reduced appetite, particularly during dose increases. These effects were consistently reported across the SUSTAIN trial program that supported Ozempic’s approval and tend to fade somewhat as the body adjusts, though not for everyone. Rare but more serious concerns include gallbladder problems, pancreatitis, and a boxed warning about thyroid C-cell tumors seen in rodent studies — a risk not established in humans, but the reason the drug carries a warning and is not recommended for people with a personal or family history of medullary thyroid carcinoma or MEN 2 syndrome.

Longer-term questions remain genuinely open, including how much muscle mass accompanies weight loss on these drugs and what happens metabolically after stopping. Both are active areas of ongoing research rather than settled facts.

The takeaway

Ozempic is semaglutide: a well-studied GLP-1 receptor agonist approved for type 2 diabetes and, separately, for cardiovascular risk reduction in people who already have heart disease. Its weight-loss effect is real and mechanistically expected, but the drug approved for that purpose under FDA labeling is Wegovy, not Ozempic. Whether any of these medications, at any dose, is appropriate for a given person is a decision that belongs with a prescribing clinician who knows the full medical history involved.